Please login first | Sign up Login

Dictionary name: bio2rdf-lodqa

Creator:

michel.dumontier@gmail.com

Description:

labels for LODQA, bio2rdf version

Entry nameIDLabel
1-30 / 578260 show all
*03:01:01:01 - lamotrigine associationhttp://bio2rdf.org/pharmgkb_resource:27297
0.3% tobramycinhttp://bio2rdf.org/drugbank_resource:0.3%-tobramycin
0.4% Lidocaine Hydrochloride and 5% Dextrose Injection Usphttp://bio2rdf.org/drugbank_resource:0.4%-Lidocaine-Hydrochloride-and-5%-Dextrose-Injection-Usp
0.5% loteprednol etabonatehttp://bio2rdf.org/drugbank_resource:0.5%-loteprednol-etabonate
0610009K11Rik, a testis-specific and germ cell nuclear receptor-interacting protein.http://bio2rdf.org/pubmed:18082624
100-fold higher frequency in southern China than Europehttp://bio2rdf.org/omim_resource:9e62f578464991fcd5eb976ee2fd049b
10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamidehttp://bio2rdf.org/pharmgkb:PA165817198
(−)-10,11-dihydroxyaporphinehttp://bio2rdf.org/drugbank_vocabulary:(−)-10,11-dihydroxyaporphine
10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diaminehttp://bio2rdf.org/drugbank:DB06932
10-15% with primarily defects of cellular immunity, not manifesting until >2yrs of agehttp://bio2rdf.org/omim_resource:0b91f2e2549bc821be66bf4ed866f43c
1024C-T (R342X) is a recurrent PHF6 mutation also found in the original Borjeson-Forssman-Lehmann syndrome family. (Letter)http://bio2rdf.org/pubmed:15241480
10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketonehttp://bio2rdf.org/drugbank_vocabulary:10-(2-(Dimethylamino)propyl)phenothiazin-2-yl-methyl-ketone
1.02 kb genomic deletion in 85% of Batten disease alleles worldwidehttp://bio2rdf.org/omim_resource:a1808bf48dad169b95fa9e5a3490f477
10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketonehttp://bio2rdf.org/drugbank_vocabulary:10-(3-dimethylaminopropyl)phenothiazin-3-yl-methyl-ketone
10-{4-Dimethylamino-5-[4-Hydroxy-6-Methyl-5-(6-Methyl-5-Oxo-Tetrahydro-Pyran-2-Yloxy)-Tetrahydro-Pyrane-2-Yloxy]-6-Methyl-Tetrahydro-Pyran-2-Yloxy}-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dionehttp://bio2rdf.org/drugbank:DB01806
10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dionehttp://bio2rdf.org/drugbank:DB04131
105AD7http://bio2rdf.org/drugbank:DB05113
109th ENMC International Workshop: 5th workshop on nemaline myopathy, 11th-13th October 2002, Naarden, The Netherlands.http://bio2rdf.org/pubmed:12899878
(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONEhttp://bio2rdf.org/drugbank:DB07768
10alpha-Isopregnenonehttp://bio2rdf.org/drugbank_vocabulary:10alpha-Isopregnenone
10-CF3C(OH)2-DDACTHFhttp://bio2rdf.org/drugbank:DB03546
10-deacetylbaccatin III 10-O-acetyltransferase activityhttp://bio2rdf.org/go:0050643
(10E,12Z)-octadeca-10,12-dienoic acidhttp://bio2rdf.org/drugbank:DB04746
10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain.http://bio2rdf.org/pubmed:8034674
10-formyltetrahydrofolate biosynthetic processhttp://bio2rdf.org/go:0009257
10-formyltetrahydrofolate catabolic processhttp://bio2rdf.org/go:0009258
10-formyltetrahydrofolate metabolic processhttp://bio2rdf.org/go:0009256
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityhttp://bio2rdf.org/go:0033885
10-hydroxyamitriptylinehttp://bio2rdf.org/pharmgkb:PA165946747
10-hydroxydihydrosanguinarine 10-O-methyltransferase activityhttp://bio2rdf.org/go:0030779

Back